Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health reports news on its virtual care business, including financial results, segment performance, product innovation, technology investment, and governance updates. The company delivers and orchestrates care across patients, care providers, platforms, and partners through relationships with health plans, employers, providers, health systems, and consumers.
Recurring updates focus on Integrated Care, which includes virtual care solutions such as primary care, mental health, chronic care management, and telehealth enablement, and BetterHelp, the company’s direct-to-consumer online mental health offering. Company news also includes earnings calls, investor conference participation, board appointments and retirements, inducement equity awards, and strategic commentary on its clinical model and care-delivery platform.
Teladoc Health (NYSE: TDOC) has appointed financial executive Mark V. Anquillare, former president and chief operating officer of Verisk Analytics, to its board of directors, effective August 3, 2026. He will serve on the board’s Audit and Compensation committees.
According to Teladoc Health, Anquillare brings over 30 years of financial and executive leadership, including roles as Verisk’s chief financial officer and chief operating officer, where he led its 2009 IPO and oversaw insurance and government-facing businesses. He currently serves on the boards of Guidewire Software, RegEd and Bamboo Insurance and previously served on TruBridge’s board. He holds an MBA from Rutgers Business School and a BBA from the University of Notre Dame.
Teladoc Health (NYSE: TDOC) reported Second Quarter 2026 revenue of $606.9 million, down 4% year-over-year, with a net loss of $38.9 million ($0.21 per share) and adjusted EBITDA of $65.7 million, down 5%.
Integrated Care revenue rose 1% to $394.3 million with a 16.5% adjusted EBITDA margin, while BetterHelp revenue fell 12% to $212.6 million with a 0.2% margin. U.S. revenue declined 6% and international revenue grew 7%. Chronic care program enrollment increased 14% to 1.272 million, and BetterHelp paying users declined 11%.
For full-year 2026, Teladoc Health expects revenue of $2.36–$2.45 billion, adjusted EBITDA of $271–$303 million, free cash flow of $130–$170 million, Integrated Care revenue growth of 0.8–2.4%, and BetterHelp revenue decline of 19.0–12.7%.
Teladoc Health (NYSE: TDOC) will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after the market close. The company will host a conference call to review the results at 5:00 p.m. ET the same day.
U.S. participants can join by dialing 833-461-5787 with meeting ID 478 236 923, while international participants can obtain local numbers via a dedicated link. A live audio webcast and an on-demand replay (available for about 90 days) will be accessible through Teladoc Health's investor relations events webpage.
Teladoc Health (NYSE: TDOC) granted an employment inducement award to new BetterHelp Head of Product, David Packles. Effective July 1, 2026, he received 50,000 restricted stock units of common stock.
The RSUs vest one-third after one year, then quarterly over two additional years, under the 2023 Employment Inducement Incentive Award Plan pursuant to NYSE Rule 303A.08.
SenesTech (NASDAQ: SNES) appointed veteran sales executive Jack Karabees as Executive Vice President of Sales. He will lead the sales organization, focusing on revenue growth, broader market penetration and stronger customer relationships.
Karabees has decades of B2B sales leadership and has already consulted for SenesTech on commercial strategy.
Teladoc Health (NYSE: TDOC) made its virtual care services available through Walmart’s Better Care Services, expanding access for insured and cash-pay customers.
Walmart customers can use Teladoc for 24/7 urgent care, dermatology and nutrition visits at a $89 cash-pay price, with prescriptions eligible for fast same-day delivery through Walmart in many locations.
The collaboration builds on the January launch of Teladoc’s BetterHelp mental health services on the same platform, reflecting a shared focus on more convenient, connected and affordable care.
Teladoc Health (NYSE: TDOC) subsidiary BetterHelp announced participation in the Institute of Patient Safety and Quality of Virtual Care, a Teladoc-affiliated Patient Safety Organization (PSO). This partnership aims to use protected safety-event reporting and clinical data to strengthen quality, identify risks, and improve virtual mental health outcomes across BetterHelp’s network of 30,000 therapists serving millions worldwide.
Teladoc Health (NYSE: TDOC) reported First Quarter 2026 results: revenue $613.8M (down 2% YoY), net loss $63.8M (or $0.36/share), and adjusted EBITDA $58.2M (flat YoY). Integrated Care revenue rose 2% to $395.4M; BetterHelp revenue fell 9% to $218.4M. Company reaffirmed full‑year outlook ranges for 2026.
Teladoc Health (NYSE: TDOC) will release first quarter 2026 financial results on April 29, 2026 after the market close and will host a conference call at 5:00 p.m. ET that day.
The call offers a live audio webcast, international dial‑ins using conference ID 2214924, and a replay that will remain available for approximately 90 days.
Teladoc Health (NYSE: TDOC) appointed Susan Salka to its board of directors, effective March 30, 2026. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. Ms. Salka will serve on the board’s audit and compensation committees.
Ms. Salka is the former president and CEO of AMN Healthcare, served 33 years there, led 26 acquisitions and helped grow revenue to over $5 billion. She currently serves on the board of Parexel and previously served on the boards of McKesson, Beckman Coulter and Playtex. She holds an MBA in Finance and a BA in Accounting and Economics.